期刊文献+

K-ras反义核酸抑制肺腺癌细胞A549的生长 被引量:1

Antisense nucleic acid of K-ras inhibits growth of lung adenocarcinoma cancer cell A549
下载PDF
导出
摘要 目的:探讨K-ras反义核酸抑制肺癌生长的机制。方法:应用Western blotting检测K-ras基因在6例肺腺癌标本和A549细胞中的表达;构建K-ras基因的反义表达载体(命名为antisense-K-ras-pcDNA3.1),转染后,MTT法测细胞的生长曲线,Annexin V检测细胞凋亡;Western blotting检测cyclin A、cyclin D1、cyclin E、CDK2、CDK4、P53、Rb和caspase-3的表达。结果:在A549细胞和6例肺腺癌标本中,A549细胞和4例标本中K-ras基因高表达;MTT结果显示从第4 d开始,转染K-ras反义核酸的细胞生长明显受到抑制,而且细胞凋亡现象较明显;Western blotting显示转染反义K-ras基因的细胞中cyclin A、cyclin D1、cyclin E、CDK2和CDK4的表达降低,而caspase-3、P53和Rb的表达升高。结论:K-ras基因反义核酸能够抑制细胞生长,可能与cyclin A、cyclinD1、cyclin E、CDK2和CDK4的表达降低和caspase-3、P53、Rb的表达升高有关。 AIM: To explore the mechanism of inhibiting lung adenocarcinoma cancer mediated by antisense nucleic acid of K-ras.METHODS: The expression of K-ras was detected in A549 cells and 6 lung adenocarinoma samples.The antisense expression vector of K-ras was successfully constucted(named antisense-K-ras-pcDNA3.1).After transfection,the growth curve and Apoptosis were determined by MTT assay and Annexin V staining,respectively.Cyclin A,cyclin D1,cyclin E,CDK2,CDK4,P53,Rb and caspase-3 were detected by Western blotting.RESULTS: K-ras was highly expressed in 4 samples of lung adenocarcinoma and A549 cells.In A549 cells transfected with antisense nucleic acid of K-ras,the cell growth was significantly inhibited and the apoptosis was visible.The expression levels of cyclin A,cyclin D1,cyclin E,CDK2 and CDK4 were significantly decreased,and the expression levels of P53,Rb and caspase-3 were significantly increased.CONCLUSION: The growth inhibition in A549 cells mediated by antisense nucleic acid of K-ras is related to the decreases in the expression of cyclin A,cyclin D1,cyclin E,CDK2 and CKD4,and the increases in the expression of P53,Rb and caspase-3.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第11期2096-2100,共5页 Chinese Journal of Pathophysiology
基金 山东省高等学校科技计划(No.J08LG51) 山东省自然科学基金资助项目(No.Y2008C164) 烟台市科学技术发展计划(No.2008162)
关键词 K-RAS基因 反义核酸 细胞周期 细胞凋亡 肺肿瘤 K-ras genes Antisense nucleic acid Cell cycle Apoptosis Lung neoplasms
  • 相关文献

参考文献12

  • 1Younes N,Fulton N,Tanaka R,et al.The presense of K-12 rasmutations in duodenal adenocarcinomas and the absence of rasmutations in other small bowel adenocarcinomas and carcinoid tumors[J].Cancer,1997,79(9):1804-1808.
  • 2Ma P,Magut M,Faller DV,et al.The role of Ras in T lymphocyte activation[J].Cell Signal,2002,14(10):849-859.
  • 3王启钊,刁勇,吕颖慧,李招发,许瑞安.突变型K-ras siRNA抑制肺癌A549细胞的增殖和迁移并诱导细胞凋亡[J].中国肿瘤生物治疗杂志,2009,16(6):564-569. 被引量:1
  • 4Suda K,Tomizawa K,Mitsudomi T.Biological and clinical significance of KRAS mutations in lung cancer:an oncogenic driver that contrasts with EGFR mutation[J].Cancer Metastasis Rev,2010,29(1):49-60.
  • 5李尊岭,邵淑红,谢书阳,岳真,马颖.CyclinD1反义核酸诱导肺腺癌细胞A549的凋亡[J].生理学报,2011,63(3):261-266. 被引量:8
  • 6Lozano MD,Zulueta JJ,Echeveste JI,et al.Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients:correlation with clinical outcomes[J].Oncologist,2011,16(6):877-885.
  • 7Findeiss S,Schmidtke C,Stadler PF,et al.A novel family of plasmid-transferred anti-sense ncRNAs[J].RNA Biol,2010,7(2):120-124.
  • 8Dancey JE.Agents targeting ras signaling pathway[J].Curr Pharm Des,2002,8(25):2259-2267.
  • 9Akli S,Keyomarsi K.Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy[J].Cancer Biol Ther,2003,2(4 Suppl 1):S38-S47.
  • 10叶孟,林蕾,潘宏铭,方勇,吴金民.Caspase 3抑制剂抑制羟基喜树碱对人乳腺癌Bcap37细胞NF-κB的激活[J].中国病理生理杂志,2007,23(8):1508-1511. 被引量:3

二级参考文献48

共引文献22

同被引文献34

  • 1Lyronis ID, Baritaki S, Bizakis I, et al. K-ras mutation, HPV infection and smoking or alcohol abuse positively cor- relate with esophageal squamous carcinoma [ J ]. Pathol Oncol Res, 2008, 14(3) :267-273.
  • 2Tasioudi KE, Saetta AA, Sakellariou S, et al. pERK acti- vation in esophageal carcinomas: clinicopathological asso- ciations[J]. Pathol Res Pract, 2012, 208(7) : 398-404.
  • 3Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the search continues [ J ]. Future Med Chem, 2011, 3(14) :1787-1808.
  • 4Graziosi L, Mencarelli A, Santorelli C, et al. Mechanistic role of p38 MAPK in gastric cancer dissemination in a ro- dent model peritoneal metastasis [ J ]. Eur J Pharmacol, 2012, 674 ( 2-3 ) : 143-152.
  • 5Sommerer F, Vieth M, Markwarth A, et al. Mutations of BRAF and KRAS2 in the development of Barrett's adeno- carcinoma [ J ]. Oncogene, 2004, 23 (2) : 554- 558.
  • 6Birner P, Jesch B, Schuhheis A, et al. RAF-kinase in- hibitor protein (RKIP) downregulation in esophageal canc- er and its metastases [ J ]. Clin Exp Metastasis, 2012, 29 (6) :551-559.
  • 7Gao C, Pang L, Ren C, et al. Prognostic value of raf ki- nase inhibitor protein in esophageal squamous cell carcino- ma[J]. Pathol Oncol Res, 2012, 18(2) :471- 477.
  • 8Kim HS, Won KY, Kim GY, et al. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squa- mous cell carcinoma [J]. Pathol Res Pract, 2012, 208 (5) :292- 299.
  • 9Keswani RN, Chumsangsri A, Mustafi R, et al. Sorafenib inhibits MAPK- mediated proliferation in a Barrett's esoph- ageal adenocarcinoma cell line[ J]. Dis Esophagus, 2008, 21(6) :514-521.
  • 10Gao SY, Li EM, Cui L, et al. Spl and AP-1 regulate ex- pression of the human gene VIL2 in esophageal carcinoma cells[ J]. J Biol Chem, 2009, 284(12) :7995- 8004.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部